Who are Valinor's investors?

Valinor's investors include Campus Founders Fund, Harpoon Ventures, Mythos Ventures Management, Llc, Castle Island Ventures, Maven 11.

How much funding has Valinor raised?

Valinor has disclosed $25M raised across 1 round.

Valinor

7 known investors

Find your way into Valinor

Paths you didn't know you had: your email and LinkedIn already hold routes to the Valinor team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Valinor Discovery generates patient-derived datasets combining multi-omics and clinical data to enable machine learning applications in drug development. The company collects longitudinal data across molecular and imaging assays to create virtual patient profiles for pharmaceutical research.

AI & Machine Learning Biotech Medical Devices

Investors · 7

Campus Founders Fundlisted by Campus Founders FundSalt Lake City · $10K – $50K

Harpoon Ventureslisted by Harpoon VenturesSan Diego · $100K – $5M

How we know: Harpoon Ventures's portfolio page · Not right? Tell us

Mythos Ventures Management, Llclisted by Mythos Ventures Management, LlcSeattle · $100K – $2M

How we know: Mythos Ventures Management, Llc's portfolio page · Not right? Tell us

Castle Island VenturesreportedBoston · $100K – $5M

How we know: funding news · pymnts.com · Not right? Tell us

Maven 11reportedAmsterdam

How we know: fortune.com · Not right? Tell us

Also in the syndicate · 2

SusquehannaTeraWulf

Funding

SEC filings, press & company announcements

$25M disclosed across 1 round · 2026

$25MSeedMar 2026 · 4 sources
Castle Island Ventures (lead), Maven 11, Susquehanna, TeraWulf
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 1

NuvalentNuvalent is a biopharmaceutical company focused on structure-based drug discovery and the development of precision oncology therapies. Its team spans chemistry, biology, translational and clinical development, and commercial functions supporting cancer drug programs.

Companies working in the same space as Valinor.

Frequently asked questions

What does Valinor do?: Valinor Discovery generates patient-derived datasets combining multi-omics and clinical data to enable machine learning applications in drug development. The company collects longitudinal data across molecular and imaging assays to create virtual patient profiles for pharmaceutical research.
Who are Valinor's investors?: Valinor's investors include Campus Founders Fund, Harpoon Ventures, Mythos Ventures Management, Llc, Castle Island Ventures, Maven 11.
How much funding has Valinor raised?: Valinor has disclosed $25M raised across 1 round.